Elon Musk explained in a post on X that how the implant connect the human brain to the electronic device.

On Tuesday, Elon Musk revealed that Neuralink, his company, successfully implanted the inaugural brain chip into a human patient. According to the billionaire, the initial findings show great promise.

He also stated that Neuralink’s first product’s name is Telepathy.

The startup, authorized by the US health regulatory body to commence the first human trial of its implant in the previous year, intends to utilize the technology to assist individuals suffering from paralysis.

In a post on X, Musk detailed how the implant establishes a connection between the brain and various electronic devices, highlighting its potential utility for individuals with physical disabilities.

Working process of the device

He mentioned “Enables control of your phone or computer, and through them almost any device, just by thinking. Initial users will be those who have lost the use of their limbs. Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal,“

Neuralink’s commentary :

Neuralink stated that the implants, constructed from “ultra-fine” threads, have the capability to transmit signals from the brain and link them to commands on an electronic device.

Neuralink stated ,The implants, made of “ultra-fine” threads, can transmit signals from the brain and connect those to commands on an electronic device.

As per their official website, the company is dedicated to developing a “generalized brain interface to restore autonomy to those with unmet medical needs.” The exploratory study, known as PRIME (Precise Robotically Implanted Brain-Computer Interface), will encompass quadriplegic patients, individuals with spinal cord injuries, and those affected by amyotrophic lateral sclerosis (ALS).

Safety Measures:

Musk’s ambitious initiative to bring telepathy into existence has faced criticism, with the company being fined this month for breaching trial safety protocols. The $5-billion company was additionally accused of providing misleading information to investors regarding the safety of the technology, as animal testing results revealed instances of paralysis, seizures, and brain swelling in the study’s subjects.